BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18956417)

  • 1. Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy.
    Waters EA; Chen J; Yang X; Zhang H; Neumann R; Santeford A; Arbeit J; Lanza GM; Wickline SA
    Magn Reson Med; 2008 Nov; 60(5):1232-6. PubMed ID: 18956417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.
    Neubauer AM; Myerson J; Caruthers SD; Hockett FD; Winter PM; Chen J; Gaffney PJ; Robertson JD; Lanza GM; Wickline SA
    Magn Reson Med; 2008 Nov; 60(5):1066-72. PubMed ID: 18956457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative (1)H MRI, (19)F MRI, and (19)F MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles.
    Kok MB; de Vries A; Abdurrachim D; Prompers JJ; Grüll H; Nicolay K; Strijkers GJ
    Contrast Media Mol Imaging; 2011; 6(1):19-27. PubMed ID: 20648660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activatable 19F MRI nanoparticle probes for the detection of reducing environments.
    Nakamura T; Matsushita H; Sugihara F; Yoshioka Y; Mizukami S; Kikuchi K
    Angew Chem Int Ed Engl; 2015 Jan; 54(3):1007-10. PubMed ID: 25413833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging.
    de Vries A; Moonen R; Yildirim M; Langereis S; Lamerichs R; Pikkemaat JA; Baroni S; Terreno E; Nicolay K; Strijkers GJ; Grüll H
    Contrast Media Mol Imaging; 2014; 9(1):83-91. PubMed ID: 24470297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
    Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
    Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Neubauer AM; Caruthers SD; Hockett FD; Wickline SA
    Curr Top Dev Biol; 2005; 70():57-76. PubMed ID: 16338337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
    Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
    Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic hemangioma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients.
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Kajita K; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
    Eur J Radiol; 2009 May; 70(2):325-30. PubMed ID: 18321673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles.
    Anderson SA; Rader RK; Westlin WF; Null C; Jackson D; Lanza GM; Wickline SA; Kotyk JJ
    Magn Reson Med; 2000 Sep; 44(3):433-9. PubMed ID: 10975896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticles.
    Giraudeau C; Geffroy F; Mériaux S; Boumezbeur F; Robert P; Port M; Robic C; Le Bihan D; Lethimonnier F; Valette J
    Angiogenesis; 2013 Jan; 16(1):171-9. PubMed ID: 23053783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents.
    Neubauer AM; Caruthers SD; Hockett FD; Cyrus T; Robertson JD; Allen JS; Williams TD; Fuhrhop RW; Lanza GM; Wickline SA
    J Cardiovasc Magn Reson; 2007; 9(3):565-73. PubMed ID: 17365236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS.
    Waters EA; Chen J; Allen JS; Zhang H; Lanza GM; Wickline SA
    J Cardiovasc Magn Reson; 2008 Sep; 10(1):43. PubMed ID: 18817557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.
    Kaneda MM; Caruthers S; Lanza GM; Wickline SA
    Ann Biomed Eng; 2009 Oct; 37(10):1922-33. PubMed ID: 19184435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of bioresponsive chelates and perfluorinated lipid nanoparticles enables in vivo MRI probe quantification.
    Gambino G; Gambino T; Angelovski G
    Chem Commun (Camb); 2020 Aug; 56(66):9433-9436. PubMed ID: 32687130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla.
    Caruthers SD; Neubauer AM; Hockett FD; Lamerichs R; Winter PM; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
    Invest Radiol; 2006 Mar; 41(3):305-12. PubMed ID: 16481914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes.
    Marsh JN; Partlow KC; Abendschein DR; Scott MJ; Lanza GM; Wickline SA
    Ultrasound Med Biol; 2007 Jun; 33(6):950-8. PubMed ID: 17434667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons.
    Southworth R; Kaneda M; Chen J; Zhang L; Zhang H; Yang X; Razavi R; Lanza G; Wickline SA
    Nanomedicine; 2009 Sep; 5(3):359-67. PubMed ID: 19523428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical perspectives of hybrid proton-fluorine magnetic resonance imaging and spectroscopy.
    Wolters M; Mohades SG; Hackeng TM; Post MJ; Kooi ME; Backes WH
    Invest Radiol; 2013 May; 48(5):341-50. PubMed ID: 23211551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High F-Content Perfluoropolyether-Based Nanoparticles for Targeted Detection of Breast Cancer by
    Zhang C; Moonshi SS; Wang W; Ta HT; Han Y; Han FY; Peng H; Král P; Rolfe BE; Gooding JJ; Gaus K; Whittaker AK
    ACS Nano; 2018 Sep; 12(9):9162-9176. PubMed ID: 30118590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.